000 01273 a2200325 4500
005 20250516190535.0
264 0 _c20140303
008 201403s 0 0 eng d
022 _a1558-8238
024 7 _a10.1172/JCI71602
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeathington, Nathaniel M
245 0 0 _aEmerging therapies targeting the ubiquitin proteasome system in cancer.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cJan 2014
300 _a6-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xpharmacology
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aProteasome Inhibitors
_xpharmacology
650 0 4 _aUbiquitin-Protein Ligases
_xantagonists & inhibitors
650 0 4 _aUbiquitination
700 1 _aMallampalli, Rama K
773 0 _tThe Journal of clinical investigation
_gvol. 124
_gno. 1
_gp. 6-12
856 4 0 _uhttps://doi.org/10.1172/JCI71602
_zAvailable from publisher's website
999 _c23409338
_d23409338